Client News

AiCuris AG Announces Dr. Stefan Oschmann, Former Merck CEO, to Chair the AiCuris Supervisory Board

Abivax reports excellent efficacy and safety of ABX464 in phase 2b clinical trial in ulcerative colitis and plans to proceed to phase 3

Tony Gibney Joins InflaRx Board of Directors

Tony Gibney Joins InflaRx Board of Directors

CatalYm to Present Initial Data of First-in-Human Trial of GDF-15 neutralizing antibody CTL-002 at the 2021 ASCO Annual Meeting

XPhyto Rapid Point-of-Care COVID-19 PCR Test Offered for Sale in Germany

InflaRx Announces Positive Topline Results for Vilobelimab from the U.S. Phase II ANCA-Associated Vasculitis IXPLORE Study

CatalYm GmbH: CatalYm Appoints Industry Leader Dr. Phil L’Huillier as Chief Executive Officer

HeartBeat.bio AG to Reinvent Cardiac Drug Discovery

VAXIMM Announces Participation at Scientific and Industry Events in May